Wells Fargo’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.99K | Hold |
3,150
| – | – | ﹤0.01% | 5965 |
|
|
2025
Q4 | $15.2K | Hold |
3,150
| – | – | ﹤0.01% | 5861 |
|
|
2025
Q3 | $8.98K | Sell |
3,150
-14,000
| -82% | -$36.3K | ﹤0.01% | 5968 |
|
|
2025
Q2 | $26.2K | Sell |
17,150
-5,600
| -25% | -$8.09K | ﹤0.01% | 5715 |
|
|
2025
Q1 | $28.2K | Sell |
22,750
-1,840
| -7% | -$2.73K | ﹤0.01% | 5591 |
|
|
2024
Q4 | $44.3K | Buy |
24,590
+12,500
| +103% | +$23.3K | ﹤0.01% | 5530 |
|
|
2024
Q3 | $25.6K | Sell |
12,090
-700
| -5% | -$1.52K | ﹤0.01% | 5566 |
|
|
2024
Q2 | $23.9K | Sell |
12,790
-150
| -1% | -$393 | ﹤0.01% | 5534 |
|
|
2024
Q1 | $34.3K | Sell |
12,940
-1,354
| -9% | -$3.75K | ﹤0.01% | 5399 |
|
|
2023
Q4 | $44K | Sell |
14,294
-1,250
| -8% | -$2.97K | ﹤0.01% | 5322 |
|
|
2023
Q3 | $24.6K | Sell |
15,544
-375
| -2% | -$733 | ﹤0.01% | 5513 |
|
|
2023
Q2 | $31.3K | Sell |
15,919
-560
| -3% | -$1.07K | ﹤0.01% | 5608 |
|
|
2023
Q1 | $31.8K | Sell |
16,479
-500
| -3% | -$1.25K | ﹤0.01% | 5413 |
|
|
2022
Q4 | $35.7K | Sell |
16,979
-250
| -1% | -$567 | ﹤0.01% | 5012 |
|
|
2022
Q3 | $40K | Buy |
17,229
+5,400
| +46% | +$16.4K | ﹤0.01% | 5051 |
|
|
2022
Q2 | $33K | Sell |
11,829
-1,100
| -9% | -$3.87K | ﹤0.01% | 5210 |
|
|
2022
Q1 | $59K | Sell |
12,929
-6,543
| -34% | -$36K | ﹤0.01% | 5569 |
|
|
2021
Q4 | $158K | Sell |
19,472
-14,148
| -42% | -$139K | ﹤0.01% | 5392 |
|
|
2021
Q3 | $423K | Buy |
33,620
+4,690
| +16% | +$65K | ﹤0.01% | 4746 |
|
|
2021
Q2 | $448K | Sell |
28,930
-1,542
| -5% | -$25.9K | ﹤0.01% | 4675 |
|
|
2021
Q1 | $616K | Buy |
30,472
+3,640
| +14% | +$90K | ﹤0.01% | 4576 |
|
|
2020
Q4 | $726K | Sell |
26,832
-1,365
| -5% | -$30.6K | ﹤0.01% | 4256 |
|
|
2020
Q3 | $522K | Sell |
28,197
-2,671
| -9% | -$47.4K | ﹤0.01% | 4305 |
|
|
2020
Q2 | $550K | Sell |
30,868
-7,184
| -19% | -$109K | ﹤0.01% | 4259 |
|
|
2020
Q1 | $350K | Sell |
38,052
-3,755
| -9% | -$56K | ﹤0.01% | 4304 |
|
|
2019
Q4 | $716K | Buy |
41,807
+3,663
| +10% | +$48.9K | ﹤0.01% | 4094 |
|
|
2019
Q3 | $397K | Sell |
38,144
-1,460
| -4% | -$19.6K | ﹤0.01% | 4528 |
|
|
2019
Q2 | $618K | Sell |
39,604
-3,536
| -8% | -$63.1K | ﹤0.01% | 4239 |
|
|
2019
Q1 | $791K | Buy |
43,140
+10,805
| +33% | +$191K | ﹤0.01% | 4048 |
|
|
2018
Q4 | $539K | Sell |
32,335
-7,687
| -19% | -$178K | ﹤0.01% | 4283 |
|
|
2018
Q3 | $1.13M | Sell |
40,022
-5,068
| -11% | -$146K | ﹤0.01% | 3881 |
|
|
2018
Q2 | $1.28M | Buy |
45,090
+17,607
| +64% | +$524K | ﹤0.01% | 3810 |
|
|
2018
Q1 | $866K | Buy |
27,483
+13,866
| +102% | +$438K | ﹤0.01% | 4019 |
|
|
2017
Q4 | $397K | Sell |
13,617
-3,366
| -20% | -$91.7K | ﹤0.01% | 4554 |
|
|
2017
Q3 | $483K | Buy |
16,983
+7,433
| +78% | +$192K | ﹤0.01% | 4359 |
|
|
2017
Q2 | $247K | Buy |
9,550
+5,435
| +132% | +$130K | ﹤0.01% | 4651 |
|
|
2017
Q1 | $99K | Buy |
+4,115
| New | +$86.4K | ﹤0.01% | 5208 |
|
|
2016
Q4 | – | Sell |
-400
| Closed | -$10K | – | 6263 |
|
|
2016
Q3 | $10K | Hold |
400
| – | – | ﹤0.01% | 5755 |
|
|
2016
Q2 | $11K | Hold |
400
| – | – | ﹤0.01% | 5637 |
|
|
2016
Q1 | $11K | Buy |
+400
| New | +$9.63K | ﹤0.01% | 5664 |
|
|
2015
Q3 | – | Sell |
-400
| Closed | -$14K | – | 6222 |
|
|
2015
Q2 | $14K | Buy |
+400
| New | +$14K | ﹤0.01% | 5709 |
|
Other funds holding CLLS
BGI
LFCM
NAMI
Wells Fargo's CLLS Position: Q1 2026 in Review
Wells Fargo held its Cellectis (CLLS) position steady in Q1 2026 at 3,150 shares worth $9.99K. The position accounts for ﹤0.01% of the portfolio, ranked #5965.
Wells Fargo first reported a position in CLLS in Q2 2015 and has held it in 41 quarters since. The position peaked at $1.28M in Q2 2018. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.
- Wells Fargo held 3,150 shares of Cellectis worth $9.99K as of Q1 2026.
- Wells Fargo left its Cellectis share count unchanged in Q1 2026.
- Cellectis made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5965 holding.
- Wells Fargo first reported a position in Cellectis in Q2 2015 and has held it in 41 quarters since.
- Wells Fargo's Cellectis position peaked at $1.28M in Q2 2018.
- 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.